While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

Health authorities need to be concerned about bird flu, but the risk to the public is low. You’re reading The Checkup With Dr ...

European agencies call for better preparedness and greater information sharing on avian flu as they identify new mutations ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical ...

Researchers at Texas Biomed have identified nine mutations in a strain of bird flu found in a person in Texas. Bad news: This ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine ... The H5N1 virus has raised concern among health ...